CanadaBis Capital (CANB) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
25 Feb, 2026Executive summary
Achieved positive adjusted EBITDA of $440,665 for Q3 2025, reflecting operational efficiency despite a challenging cannabis market.
Gross revenue reached $5.5 million for Q3 2025, with a 6% increase in gross profit margin compared to prior periods.
Launched new diamond and Keef-coated pre-rolls, which sold out multiple times, indicating strong market demand.
Preparing to launch innovative vape hardware later in 2025 to re-enter the vape market.
Financial highlights
Gross revenue for Q3 2025 was $5.5 million, reflecting SKU rationalization and seasonally weak sales.
Adjusted EBITDA remained robust at $440,665, consistent with previous quarters despite lower revenue.
SG&A expenses reduced by 30% year-over-year to $1.4 million, supporting profitability.
Outlook and guidance
Focus remains on cost management, operational optimization, and product innovation to drive future growth.
Evaluating expansion into flower sales, international licensing, and bulk extract B2B channels.
Management expects continued operational efficiency and strategic growth opportunities.
Latest events from CanadaBis Capital
- Q3 2024 delivered robust revenue, profit, and margin gains, fueled by innovation and efficiency.CANB
Q3 202425 Feb 2026 - FY2024 net income reached $600,285, driven by new products and operational efficiencies.CANB
Q4 202425 Feb 2026 - Record revenue and profitability achieved, driven by innovation and international expansion.CANB
Q1 202525 Feb 2026 - Q2 2025 gross revenue surged 29% to $9M, with adjusted EBITDA of $434K and net earnings of $96K.CANB
Q2 202525 Feb 2026 - Gross profit and adjusted EBITDA fell despite stable revenue, with new strategies set for 2026 growth.CANB
Q4 202525 Feb 2026 - Positive cash flow and margin gains achieved despite revenue decline and market disruptions.CANB
Q1 202625 Feb 2026